Barbara Ann Karmanos Cancer Institute
3 clinical trials · 3 recruiting · OTHER
Trials by Barbara Ann Karmanos Cancer Institute
RECRUITINGNCT06908629
Addressing Social Determinants of Health Among Metro Detroit Cancer Survivors
The goal of this screening study is to determine the feasibility of completing a social needs screening tool in participants who have a past or current cancer diagnosis and reside...
Sponsor: Barbara Ann Karmanos Cancer InstituteEnrolling: 1201 location
CancerCancer SurvivorsGastrointestinal Cancers+2
RECRUITINGPhase 2NCT06107738
Iberdomide and Daratumumab As Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma
The goal of this phase 2 clinical trial is to learn if patients with Multiple Myeloma who are minimal residual disease positive after initial therapy (including an autologous stem...
Sponsor: Barbara Ann Karmanos Cancer InstituteEnrolling: 602 locations
Multiple Myeloma
RECRUITINGPhase 2NCT06420167
DapagliFLOzin in Renal AL Amyloidosis (FLORAL)
The goal of this clinical trial is to learn if an oral drug called dapagliflozin is safe and can reduce high protein levels in the urine of patients with renal amyloid light-chain...
Sponsor: Barbara Ann Karmanos Cancer InstituteEnrolling: 201 location
Renal AL Amyloidosis